Duopharma Biotech Berhad (DPHARMA):企業の財務・戦略的SWOT分析

◆英語タイトル:Duopharma Biotech Berhad (DPHARMA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81943FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥64,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥97,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Duopharma Biotech Berhad (Duopharma), formerly CCM Duopharma Biotech Berhad, focuses on research, development and commercialization of generic drugs and biosimilars. The company manufactures and distributes pharmaceutical products to treat oncology and diabetes; musculo-skeletal, alimentary tract and metabolism, dermatology and cardiovascular diseases; and nervous system and renal disorders. It also offers consumer healthcare products such as vitamins and supplements, analgesics, antacids, joint pain products and eye and skin care solutions. Duopharma has operational presence in Philippines and Singapore. The company owns and operates manufacturing facilities in Klang, Bangi and Glenmarie, Selangor, Malaysia. Duopharma is headquartered in Klang, Malaysia.

Duopharma Biotech Berhad Key Recent Developments

Mar 04,2021: Duopharma Biotech fortifies ethical culture with ISO37001 achievement and first Malaysia Pharma Company to win Beim Five Petals Gold Ethics Award
Feb 22,2021: Duopharma Biotech maintains profit momentum
Nov 12,2020: Duopharma Biotech posts another strong quarter registering PBT of RM18.57M
Nov 03,2020: Breast Cancer and Chronic Myloid Leukaemia Community welcome manufacturing of relevant drugs at Malaysia’s first HAPI facility
Oct 12,2020: Duopharma Biotech to manufacture its second oncology medicine to treat Chronic Myeloid Leukemia

This comprehensive SWOT profile of Duopharma Biotech Berhad provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Duopharma Biotech Berhad including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Duopharma Biotech Berhad – Key Information
Duopharma Biotech Berhad – Overview
Duopharma Biotech Berhad – Key Employees
Duopharma Biotech Berhad – Key Employee Biographies
Duopharma Biotech Berhad – Key Operational Heads
Duopharma Biotech Berhad – Major Products and Services
Duopharma Biotech Berhad – History
Duopharma Biotech Berhad – Company Statement
Duopharma Biotech Berhad – Locations And Subsidiaries
Duopharma Biotech Berhad
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Duopharma Biotech Berhad – Business Description
Duopharma Biotech Berhad – Corporate Strategy
Duopharma Biotech Berhad – SWOT Analysis
SWOT Analysis – Overview
Duopharma Biotech Berhad – Strengths
Duopharma Biotech Berhad – Weaknesses
Duopharma Biotech Berhad – Opportunities
Duopharma Biotech Berhad – Threats
Duopharma Biotech Berhad – Key Competitors

Section 3 – Company Financial Performance Charts

Duopharma Biotech Berhad – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Duopharma Biotech Berhad, Key Information
Duopharma Biotech Berhad, Key Ratios
Duopharma Biotech Berhad, Share Data
Duopharma Biotech Berhad, Major Products and Services
Duopharma Biotech Berhad, History
Duopharma Biotech Berhad, Key Employees
Duopharma Biotech Berhad, Key Employee Biographies
Duopharma Biotech Berhad, Key Operational Heads
Duopharma Biotech Berhad, Other Locations
Duopharma Biotech Berhad, Subsidiaries
Duopharma Biotech Berhad, Key Competitors
Duopharma Biotech Berhad, SWOT Analysis
Duopharma Biotech Berhad, Ratios based on current share price
Duopharma Biotech Berhad, Annual Ratios
Duopharma Biotech Berhad, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Duopharma Biotech Berhad (DPHARMA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vizrt Group AS.:企業の戦略的SWOT分析
    Vizrt Group AS. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Petrel Resources Plc (PET):企業の財務・戦略的SWOT分析
    Summary Petrel Resources Plc (Petrel Resources) is an oil and gas company that provides exploration and production of crude oil and natural gas across Iraq. The company provides areas of operations such as Luhais and Subba in Southern Iraq, Tano Basin in Ghana, Porcupine Basin in Ireland, and others …
  • IntriCon Corp (IIN):企業の財務・戦略的SWOT分析
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products comprise glucose monitoring, medical coils, cardiac monitoring, amplifiers, systems, plastic medical molding, support product …
  • Qatari Diar Real Estate Investment Co:企業のM&A・事業提携・投資動向
    Qatari Diar Real Estate Investment Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Qatari Diar Real Estate Investment Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • FalconStor Software Inc (FALC):企業の財務・戦略的SWOT分析
    Summary FalconStor Software Inc (FalconStor) is a technology company that offers data protection and storage virtualization solutions. The company offers freestor, continuous data protector, and network storage server. It offers freestor, which supports to manage data to deliver real-time informatio …
  • Siam Makro Public Company Limited (MAKRO):企業の財務・戦略的SWOT分析
    Siam Makro Public Company Limited (MAKRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Koninklijke Vopak NV (VPK):企業の財務・戦略的SWOT分析
    Koninklijke Vopak NV (VPK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Chesapeake Utilities Corp (CPK):企業の財務・戦略的SWOT分析
    Summary Chesapeake Utilities Corp (Chesapeake), a subsidiary of Chesapeake Energy Corp is a utility service provider that markets and distributes natural gas. The utility transmits, distributes, and markets propane, electricity, and natural gas. It also provides online bill payment, energy conservat …
  • Integrated Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Integrated Diagnostics Inc (Indi) is a medical device company that develops and distributes blood based molecular diagnostics tests for the healthcare markets. The company’s tools assist physicians in the early diagnosis of complex diseases with a non-invasive blood test, such as lung cancer …
  • PhoenixBio Co Ltd (6190)-製薬・医療分野:企業M&A・提携分析
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services which include dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and …
  • Trane Inc:企業の戦略的SWOT分析
    Trane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Nihon Kohden Corporation:企業の戦略・SWOT・財務情報
    Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report Summary Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Endurance International Group Holdings, Inc.:企業のM&A・事業提携・投資動向
    Endurance International Group Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Endurance International Group Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • ULURU Inc (ULUR):医療機器:M&Aディール及び事業提携情報
    Summary ULURU Inc (ULURU) is a medical technology company that researches, develops, and markets wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wo …
  • WPG Holdings Limited:企業の戦略・SWOT・財務情報
    WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ABT Molecular Imaging Inc:医療機器:M&Aディール及び事業提携情報
    Summary ABT Molecular Imaging Inc (ABT) is a medical imaging company engaged in the development of biomarker generator systems and related accessories. Its technology platform BG-75, a biomarker generator produces unit doses of molecular imaging drugs for positron emission tomography (PET) at the po …
  • Laboratoires Pierre Fabre SA:企業の戦略的SWOT分析
    Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Heat Biologics Inc (HTBX):企業の財務・戦略的SWOT分析
    Heat Biologics Inc (HTBX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Manulife Financial Corporation:戦略・SWOT・企業財務分析
    Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Cooper Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Cooper Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Cooper Energy Limited (CEL) is an exploration and production company that offers oil production programs. The company explores, produces, and commercializes crude oil and natural gas products. It condu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆